About
Jianjun Yu is the Chief Scientific Officer & VP, Translational Medicine at Premedicine. Jianjun Yu attended University of Michigan.
Position in the VCSift Database
- • 3 investors at Predicine are tracked.
- • 1 investors hold the Chief Scientific Officer & VP, Translational Medicine role in VCSift. Jianjun Yu is one of them.
- • 1,751 investors are based in California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- California, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Jianjun
Search Investors